stockrowOscar Health, Inc.
OSCR Healthcare Healthcare Plans
Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024.
- Revenue
- +72.1%
- EPS
- +201.9%
- Free cash flow
- −24.5%
- Total debt
- −37.0%
Quarter to September 2026, against a year earlier
Follow OSCR
Alert me
Oscar Health, Inc. (OSCR) Net income
Oscar Health, Inc.'s net income for fiscal 2025 was −$442.9M, compared with $26.1M in fiscal 2024. Over the twelve months to 30 September 2026 it was $855.7M. Over the past ten years it has ranged from −$609.6M (fiscal 2022) to $26.1M (fiscal 2024); the current reading is higher than 43% of that period. Oscar Health, Inc. ranks 7th of 12 Healthcare Plans companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$442.9M | — |
| FY2024 | $26.1M | — |
| FY2023 | −$270.6M | — |
| FY2022 | −$609.6M | — |
| FY2021 | −$571.4M | — |
| FY2020 | −$406.8M | — |
| FY2019 | −$261.2M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $167.3M | (53.76%) |
| Jun 2026 | $361.8M | (46.71%) |
| Mar 2026 | $679.0M | — |
| Dec 2025 | −$352.4M | — |
| 24 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| CI Cigna Group compare | $6.7B |
| ELV Elevance Health, Inc. compare | $5.1B |
| CNC Centene Corporation compare | $1.5B |
| HUM Humana Inc. compare | $1.3B |
| OSCR Oscar Health, Inc. | $855.7M |
| PGNY Progyny, Inc. compare | $91.0M |
| ALHC Alignment Healthcare, Inc. compare | $28.9M |
| CLOV Clover Health Investments, Corp. compare | $12.5M |
| MOH Molina Healthcare, Inc compare | −$48.0M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on OSCR
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement